Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05726318 · ClinicalTrials.gov registry record · Phase 4
Randomized Trial of Culture Directed Versus Empiric Antibiotics for Urinary Tract Infections in Older Women
A Phase 4 study of UTI, sponsored by Megan Bradley.
- Completed
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT05726318 is a Phase 4 study of UTI that has completed, run by Megan Bradley. The registered enrollment target is 70 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05726318, a Phase 4 study of UTI, has completed, sponsored by Megan Bradley.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate the feasibility of recruiting eligible subjects into a randomized trial of a culture-directed versus empiric antibiotic strategy for patient-reported urinary tract infection symptoms in older women and the adherence to study procedures.
Conditions Studied
Interventions
- DRUG Antibiotics
Study Locations (1)
Pennsylvania
- Magee Women's Hospital of UPMC - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2023-02-17 |
| Est. Completion | 2024-08-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05726318
The ClinicalTrials.gov registry entry for NCT05726318 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Megan Bradley, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with UTI appearing as the primary indexed condition, and to 1 intervention - of which Antibiotics is the first listed.
NCT05726318 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05726318 about?
NCT05726318 is a clinical study titled "Randomized Trial of Culture Directed Versus Empiric Antibiotics for Urinary Tract Infections in Older Women". To evaluate the feasibility of recruiting eligible subjects into a randomized trial of a culture-directed versus empiric antibiotic strategy for patient-reported urinary tract infection symptoms in older women and the adherence to study procedures.
What is the current status of trial NCT05726318?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2023-02-17. Estimated completion is 2024-08-02.
What conditions does trial NCT05726318 study?
This clinical trial studies the following conditions: UTI.
What interventions are being tested in trial NCT05726318?
The interventions under investigation include: Antibiotics (DRUG).
Who is sponsoring clinical trial NCT05726318?
This trial is sponsored by Megan Bradley, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05726318 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for UTI
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.